Use of a novel peptide leukotriene receptor antagonist, Ly-163443, in splanchnic artery occlusion shock

This publication has 27 references indexed in Scilit:

• Evaluation of LY163443, 1-[2-hydroxy-3-propyl-4-{[4-(1H-tetrazol-5-ylmethyl)phenoxy]methyl}phenyl]ethanone, as a pharmacologic antagonist of leukotrienes D4 and E4
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1986
• Leukotrienes as mediators of ischemia and shock
  Biochemical Pharmacology, 1986
• AUTONOMIC PHARMACOLOGY OF LEUKOTRIENES
  Journal of Autonomic Pharmacology, 1985
• Inhibitors of lipoxygenase products improve survival in traumatic shock
  Prostaglandins, 1984
• Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
  Science, 1983
• Thyrotropin-releasing hormone reverses the hypotension and bradycardia produced by leukotriene D4 in unanesthetized guinea pigs
  Prostaglandins, Leukotrienes and Medicine, 1983
• Pancreatic hydrolases and the formation of a myocardial depressant factor in shock
  American Journal of Physiology-Legacy Content, 1972
• Role of Lysosomes in the Pathogenesis of Splanchnic Ischemia Shock in Cats
  Circulation Research, 1970
• Ultrastructural Changes in the Canine Ileal Mucosal Cell After Mesenteric Arterial Occlusion
  Archives of Surgery, 1970
• THE ESTIMATION OF CATHEPSIN WITH HEMOGLOBIN AND THE PARTIAL PURIFICATION OF CATHEPSIN
  The Journal of general physiology, 1937